Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Schwinghamer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Nanotheranostics|February 3, 2025
Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain DeliveryKelly Schwinghamer, Teruna J Siahaan
Molecular Pharmaceutics|November 25, 2025
Design and Synthesis of MBP-Fc-Bifunctional Peptide Inhibitor to Improve <i>In Vivo</i> Half-Life and EfficacyRucha Mahadik, Kelly Schwinghamer, Andrea L Villela-Nava, et al.
Molecular Pharmaceutics|January 20, 2026
Targeting Hyaluronic Acid Increases Brain Retention of Intraventricular Dosed Antibodies in MiceKelly Schwinghamer, Teruna J Siahaan, Alavattam Sreedhara, et al.
Molecular Pharmaceutics|February 23, 2024
Selective Uptake of Macromolecules to the Brain in Microfluidics and Animal Models Using the HAVN1 Peptide as a Blood-Brain Barrier ModulatorKelly Schwinghamer, Stacey Line, Devin B Tesar, et al.
Molecular Pharmaceutics|July 26, 2024
Exploring How Antibody Format Drives Clearance from the BrainKelly Schwinghamer, Brian M Kopec, Ebehiremen Ayewoh, et al.
Cancers|November 11, 2022
Spermidine/Spermine N1-Acetyltransferase 1 (<i>SAT1</i>)-A Potential Gene Target for Selective Sensitization of Glioblastoma Cells Using an Ionizable Lipid Nanoparticle to Deliver siRNAVinith Yathindranath, Nura Safa, Babu V Sajesh, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Nanotheranostics|February 3, 2025
Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain DeliveryKelly Schwinghamer, Teruna J Siahaan
Molecular Pharmaceutics|November 25, 2025
Design and Synthesis of MBP-Fc-Bifunctional Peptide Inhibitor to Improve <i>In Vivo</i> Half-Life and EfficacyRucha Mahadik, Kelly Schwinghamer, Andrea L Villela-Nava, et al.
Molecular Pharmaceutics|January 20, 2026
Targeting Hyaluronic Acid Increases Brain Retention of Intraventricular Dosed Antibodies in MiceKelly Schwinghamer, Teruna J Siahaan, Alavattam Sreedhara, et al.
Molecular Pharmaceutics|February 23, 2024
Selective Uptake of Macromolecules to the Brain in Microfluidics and Animal Models Using the HAVN1 Peptide as a Blood-Brain Barrier ModulatorKelly Schwinghamer, Stacey Line, Devin B Tesar, et al.
Molecular Pharmaceutics|July 26, 2024
Exploring How Antibody Format Drives Clearance from the BrainKelly Schwinghamer, Brian M Kopec, Ebehiremen Ayewoh, et al.
Cancers|November 11, 2022
Spermidine/Spermine N1-Acetyltransferase 1 (<i>SAT1</i>)-A Potential Gene Target for Selective Sensitization of Glioblastoma Cells Using an Ionizable Lipid Nanoparticle to Deliver siRNAVinith Yathindranath, Nura Safa, Babu V Sajesh, et al.
Pageof 1